nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminosalicylic Acid—PTGS2—thyroid cancer	0.7	1	CbGaD
Aminosalicylic Acid—Pericarditis—Vandetanib—thyroid cancer	0.00827	0.0743	CcSEcCtD
Aminosalicylic Acid—Hypothyroidism—Vandetanib—thyroid cancer	0.00557	0.05	CcSEcCtD
Aminosalicylic Acid—Hypothyroidism—Sorafenib—thyroid cancer	0.00376	0.0338	CcSEcCtD
Aminosalicylic Acid—Hypoglycaemia—Vandetanib—thyroid cancer	0.00266	0.0239	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal haemorrhage—Vandetanib—thyroid cancer	0.0026	0.0233	CcSEcCtD
Aminosalicylic Acid—Mesalazine—PPARG—thyroid cancer	0.0023	0.443	CrCbGaD
Aminosalicylic Acid—Pericarditis—Epirubicin—thyroid cancer	0.00206	0.0185	CcSEcCtD
Aminosalicylic Acid—Weight decreased—Vandetanib—thyroid cancer	0.00203	0.0182	CcSEcCtD
Aminosalicylic Acid—Pericarditis—Doxorubicin—thyroid cancer	0.00191	0.0171	CcSEcCtD
Aminosalicylic Acid—Dermatitis exfoliative—Sorafenib—thyroid cancer	0.00186	0.0167	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Vandetanib—thyroid cancer	0.00177	0.0159	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Vandetanib—thyroid cancer	0.00176	0.0158	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Vandetanib—thyroid cancer	0.00156	0.014	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Vandetanib—thyroid cancer	0.00153	0.0138	CcSEcCtD
Aminosalicylic Acid—Optic neuritis—Epirubicin—thyroid cancer	0.00145	0.013	CcSEcCtD
Aminosalicylic Acid—Eruption—Epirubicin—thyroid cancer	0.00145	0.013	CcSEcCtD
Aminosalicylic Acid—Weight decreased—Sorafenib—thyroid cancer	0.00137	0.0123	CcSEcCtD
Aminosalicylic Acid—Eruption—Doxorubicin—thyroid cancer	0.00134	0.012	CcSEcCtD
Aminosalicylic Acid—Optic neuritis—Doxorubicin—thyroid cancer	0.00134	0.012	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Sorafenib—thyroid cancer	0.00132	0.0119	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Vandetanib—thyroid cancer	0.00132	0.0119	CcSEcCtD
Aminosalicylic Acid—Jaundice—Sorafenib—thyroid cancer	0.00132	0.0118	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Vandetanib—thyroid cancer	0.00125	0.0112	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Vandetanib—thyroid cancer	0.00125	0.0112	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Vandetanib—thyroid cancer	0.00124	0.0111	CcSEcCtD
Aminosalicylic Acid—Diflunisal—PTGS2—thyroid cancer	0.00124	0.238	CrCbGaD
Aminosalicylic Acid—Dermatitis atopic—Epirubicin—thyroid cancer	0.0012	0.0108	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Sorafenib—thyroid cancer	0.0012	0.0107	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Sorafenib—thyroid cancer	0.00119	0.0107	CcSEcCtD
Aminosalicylic Acid—Dermatitis atopic—Doxorubicin—thyroid cancer	0.00111	0.01	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Vandetanib—thyroid cancer	0.00111	0.00996	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.0011	0.00989	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Sorafenib—thyroid cancer	0.00105	0.00947	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00104	0.00937	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Sorafenib—thyroid cancer	0.00103	0.00928	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Vandetanib—thyroid cancer	0.00101	0.00906	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Vandetanib—thyroid cancer	0.00101	0.00906	CcSEcCtD
Aminosalicylic Acid—Anaemia—Sorafenib—thyroid cancer	0.000975	0.00876	CcSEcCtD
Aminosalicylic Acid—Mesalazine—PTGS2—thyroid cancer	0.000969	0.187	CrCbGaD
Aminosalicylic Acid—Leukopenia—Sorafenib—thyroid cancer	0.000944	0.00848	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.000892	0.00801	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Vandetanib—thyroid cancer	0.000873	0.00784	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Sorafenib—thyroid cancer	0.000844	0.00758	CcSEcCtD
Aminosalicylic Acid—Dizziness—Vandetanib—thyroid cancer	0.000844	0.00758	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Sorafenib—thyroid cancer	0.000843	0.00757	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Sorafenib—thyroid cancer	0.000836	0.00751	CcSEcCtD
Aminosalicylic Acid—Anorexia—Sorafenib—thyroid cancer	0.00082	0.00737	CcSEcCtD
Aminosalicylic Acid—Vomiting—Vandetanib—thyroid cancer	0.000811	0.00729	CcSEcCtD
Aminosalicylic Acid—Rash—Vandetanib—thyroid cancer	0.000805	0.00723	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Vandetanib—thyroid cancer	0.000804	0.00722	CcSEcCtD
Aminosalicylic Acid—Headache—Vandetanib—thyroid cancer	0.000799	0.00718	CcSEcCtD
Aminosalicylic Acid—Nausea—Vandetanib—thyroid cancer	0.000758	0.00681	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Sorafenib—thyroid cancer	0.000748	0.00672	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.000743	0.00667	CcSEcCtD
Aminosalicylic Acid—Vascular purpura—Epirubicin—thyroid cancer	0.000723	0.0065	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000704	0.00632	CcSEcCtD
Aminosalicylic Acid—Salicylic acid—PTGS2—thyroid cancer	0.000687	0.132	CrCbGaD
Aminosalicylic Acid—Dermatitis exfoliative—Epirubicin—thyroid cancer	0.000686	0.00616	CcSEcCtD
Aminosalicylic Acid—Urticaria—Sorafenib—thyroid cancer	0.000684	0.00614	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Sorafenib—thyroid cancer	0.00068	0.00611	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Sorafenib—thyroid cancer	0.00068	0.00611	CcSEcCtD
Aminosalicylic Acid—Purpura—Epirubicin—thyroid cancer	0.000672	0.00603	CcSEcCtD
Aminosalicylic Acid—Vascular purpura—Doxorubicin—thyroid cancer	0.000669	0.00601	CcSEcCtD
Aminosalicylic Acid—Hypoglycaemia—Epirubicin—thyroid cancer	0.000663	0.00596	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal haemorrhage—Epirubicin—thyroid cancer	0.000647	0.00581	CcSEcCtD
Aminosalicylic Acid—Dermatitis exfoliative—Doxorubicin—thyroid cancer	0.000635	0.0057	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Sorafenib—thyroid cancer	0.000634	0.0057	CcSEcCtD
Aminosalicylic Acid—Purpura—Doxorubicin—thyroid cancer	0.000621	0.00558	CcSEcCtD
Aminosalicylic Acid—Hypoglycaemia—Doxorubicin—thyroid cancer	0.000614	0.00551	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal haemorrhage—Doxorubicin—thyroid cancer	0.000599	0.00538	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Sorafenib—thyroid cancer	0.000589	0.00529	CcSEcCtD
Aminosalicylic Acid—Dizziness—Sorafenib—thyroid cancer	0.000569	0.00511	CcSEcCtD
Aminosalicylic Acid—Abdominal distension—Epirubicin—thyroid cancer	0.000563	0.00506	CcSEcCtD
Aminosalicylic Acid—Vomiting—Sorafenib—thyroid cancer	0.000547	0.00492	CcSEcCtD
Aminosalicylic Acid—Rash—Sorafenib—thyroid cancer	0.000543	0.00487	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Sorafenib—thyroid cancer	0.000542	0.00487	CcSEcCtD
Aminosalicylic Acid—Headache—Sorafenib—thyroid cancer	0.000539	0.00484	CcSEcCtD
Aminosalicylic Acid—Abdominal distension—Doxorubicin—thyroid cancer	0.000521	0.00468	CcSEcCtD
Aminosalicylic Acid—Nausea—Sorafenib—thyroid cancer	0.000511	0.00459	CcSEcCtD
Aminosalicylic Acid—Weight decreased—Epirubicin—thyroid cancer	0.000506	0.00455	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Epirubicin—thyroid cancer	0.000489	0.00439	CcSEcCtD
Aminosalicylic Acid—Jaundice—Epirubicin—thyroid cancer	0.000486	0.00437	CcSEcCtD
Aminosalicylic Acid—Weight decreased—Doxorubicin—thyroid cancer	0.000468	0.00421	CcSEcCtD
Aminosalicylic Acid—Agranulocytosis—Epirubicin—thyroid cancer	0.000465	0.00418	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.000452	0.00406	CcSEcCtD
Aminosalicylic Acid—Jaundice—Doxorubicin—thyroid cancer	0.00045	0.00404	CcSEcCtD
Aminosalicylic Acid—Hepatitis—Epirubicin—thyroid cancer	0.000448	0.00402	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Epirubicin—thyroid cancer	0.000442	0.00397	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Epirubicin—thyroid cancer	0.000439	0.00394	CcSEcCtD
Aminosalicylic Acid—Agranulocytosis—Doxorubicin—thyroid cancer	0.000431	0.00387	CcSEcCtD
Aminosalicylic Acid—Hepatitis—Doxorubicin—thyroid cancer	0.000414	0.00372	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Doxorubicin—thyroid cancer	0.000409	0.00367	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Doxorubicin—thyroid cancer	0.000406	0.00365	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Epirubicin—thyroid cancer	0.00039	0.0035	CcSEcCtD
Aminosalicylic Acid—Flatulence—Epirubicin—thyroid cancer	0.000384	0.00345	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Epirubicin—thyroid cancer	0.000382	0.00343	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Doxorubicin—thyroid cancer	0.000361	0.00324	CcSEcCtD
Aminosalicylic Acid—Anaemia—Epirubicin—thyroid cancer	0.00036	0.00324	CcSEcCtD
Aminosalicylic Acid—Flatulence—Doxorubicin—thyroid cancer	0.000355	0.00319	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Doxorubicin—thyroid cancer	0.000353	0.00317	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Epirubicin—thyroid cancer	0.000349	0.00313	CcSEcCtD
Aminosalicylic Acid—Anaemia—Doxorubicin—thyroid cancer	0.000333	0.00299	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.00033	0.00296	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Doxorubicin—thyroid cancer	0.000323	0.0029	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Epirubicin—thyroid cancer	0.000312	0.0028	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Epirubicin—thyroid cancer	0.000311	0.0028	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Epirubicin—thyroid cancer	0.000309	0.00278	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000305	0.00274	CcSEcCtD
Aminosalicylic Acid—Anorexia—Epirubicin—thyroid cancer	0.000303	0.00272	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Doxorubicin—thyroid cancer	0.000289	0.00259	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000288	0.00259	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Doxorubicin—thyroid cancer	0.000286	0.00257	CcSEcCtD
Aminosalicylic Acid—Anorexia—Doxorubicin—thyroid cancer	0.000281	0.00252	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Epirubicin—thyroid cancer	0.000277	0.00248	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000275	0.00247	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Epirubicin—thyroid cancer	0.00026	0.00234	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Doxorubicin—thyroid cancer	0.000256	0.0023	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000254	0.00228	CcSEcCtD
Aminosalicylic Acid—Urticaria—Epirubicin—thyroid cancer	0.000253	0.00227	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Epirubicin—thyroid cancer	0.000251	0.00226	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Epirubicin—thyroid cancer	0.000251	0.00226	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000241	0.00216	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Epirubicin—thyroid cancer	0.000234	0.00211	CcSEcCtD
Aminosalicylic Acid—Urticaria—Doxorubicin—thyroid cancer	0.000234	0.0021	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Doxorubicin—thyroid cancer	0.000233	0.00209	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Doxorubicin—thyroid cancer	0.000233	0.00209	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Epirubicin—thyroid cancer	0.000218	0.00195	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Doxorubicin—thyroid cancer	0.000217	0.00195	CcSEcCtD
Aminosalicylic Acid—Dizziness—Epirubicin—thyroid cancer	0.00021	0.00189	CcSEcCtD
Aminosalicylic Acid—Vomiting—Epirubicin—thyroid cancer	0.000202	0.00182	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Doxorubicin—thyroid cancer	0.000201	0.00181	CcSEcCtD
Aminosalicylic Acid—Rash—Epirubicin—thyroid cancer	0.000201	0.0018	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Epirubicin—thyroid cancer	0.0002	0.0018	CcSEcCtD
Aminosalicylic Acid—Headache—Epirubicin—thyroid cancer	0.000199	0.00179	CcSEcCtD
Aminosalicylic Acid—Dizziness—Doxorubicin—thyroid cancer	0.000195	0.00175	CcSEcCtD
Aminosalicylic Acid—Nausea—Epirubicin—thyroid cancer	0.000189	0.0017	CcSEcCtD
Aminosalicylic Acid—Vomiting—Doxorubicin—thyroid cancer	0.000187	0.00168	CcSEcCtD
Aminosalicylic Acid—Rash—Doxorubicin—thyroid cancer	0.000186	0.00167	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Doxorubicin—thyroid cancer	0.000185	0.00167	CcSEcCtD
Aminosalicylic Acid—Headache—Doxorubicin—thyroid cancer	0.000184	0.00166	CcSEcCtD
Aminosalicylic Acid—Nausea—Doxorubicin—thyroid cancer	0.000175	0.00157	CcSEcCtD
Aminosalicylic Acid—PTGS2—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	0.000167	0.000909	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Breast Cancer Pathway—PTEN—thyroid cancer	0.000167	0.000908	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB4—PTEN—thyroid cancer	0.000166	0.000904	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TCR Signaling Pathway—HRAS—thyroid cancer	0.000164	0.000897	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism—PPARG—thyroid cancer	0.000164	0.000896	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—C-MYB transcription factor network—CCND1—thyroid cancer	0.000163	0.000891	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—TPR—thyroid cancer	0.000162	0.000884	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TNF alpha Signaling Pathway—HRAS—thyroid cancer	0.000162	0.000881	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—NDUFA13—thyroid cancer	0.000162	0.000881	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—TRIM33—thyroid cancer	0.000161	0.00088	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—PRKAR1A—thyroid cancer	0.00016	0.00087	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	0.000158	0.000863	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signal transduction—PTEN—thyroid cancer	0.000158	0.000863	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR—PTEN—thyroid cancer	0.000157	0.000859	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by SCF-KIT—NRAS—thyroid cancer	0.000157	0.000856	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB2—PTEN—thyroid cancer	0.000157	0.000854	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 signaling—PTEN—thyroid cancer	0.000156	0.00085	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Receptor Signaling Pathway—HRAS—thyroid cancer	0.000155	0.000845	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—TCF7L1—thyroid cancer	0.000154	0.000838	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling events of B Cell Receptor (BCR)—PTEN—thyroid cancer	0.000154	0.000838	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Apoptosis—AKT1—thyroid cancer	0.000153	0.000837	CbGpPWpGaD
Aminosalicylic Acid—CHUK—MicroRNAs in cardiomyocyte hypertrophy—AKT1—thyroid cancer	0.000153	0.000837	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—TRIM24—thyroid cancer	0.000153	0.000835	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—CHST14—thyroid cancer	0.000152	0.000828	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—MINPP1—thyroid cancer	0.000151	0.000822	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Constitutive PI3K/AKT Signaling in Cancer—AKT1—thyroid cancer	0.000151	0.000821	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling of activated FGFR—NRAS—thyroid cancer	0.00015	0.000819	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB4—NRAS—thyroid cancer	0.000148	0.000806	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—PTEN—thyroid cancer	0.000147	0.0008	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—PTEN—thyroid cancer	0.000147	0.0008	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—PTEN—thyroid cancer	0.000147	0.0008	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—PTEN—thyroid cancer	0.000145	0.000793	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TCR Signaling Pathway—AKT1—thyroid cancer	0.000145	0.000792	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	0.000145	0.000788	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—PTEN—thyroid cancer	0.000144	0.000786	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CHST14—thyroid cancer	0.000144	0.000785	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—PTEN—thyroid cancer	0.000143	0.000782	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	0.000143	0.00078	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TNF alpha Signaling Pathway—AKT1—thyroid cancer	0.000143	0.000778	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by Interleukins—HRAS—thyroid cancer	0.000142	0.000775	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—BRAF—thyroid cancer	0.000142	0.000774	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—CDK1—thyroid cancer	0.000142	0.000773	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signal transduction—NRAS—thyroid cancer	0.000141	0.00077	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—C-MYB transcription factor network—NRAS—thyroid cancer	0.000141	0.000767	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR—NRAS—thyroid cancer	0.00014	0.000766	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB2—NRAS—thyroid cancer	0.00014	0.000762	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 signaling—NRAS—thyroid cancer	0.000139	0.000759	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	0.000138	0.000753	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling events of B Cell Receptor (BCR)—NRAS—thyroid cancer	0.000137	0.000748	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Receptor Signaling Pathway—AKT1—thyroid cancer	0.000137	0.000746	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—TRIM33—thyroid cancer	0.000136	0.000744	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—IFNA2—thyroid cancer	0.000136	0.000743	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Activation—PTEN—thyroid cancer	0.000136	0.00074	CbGpPWpGaD
Aminosalicylic Acid—CHUK—PI-3K cascade—AKT1—thyroid cancer	0.000136	0.00074	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by SCF-KIT—KRAS—thyroid cancer	0.000135	0.000737	CbGpPWpGaD
Aminosalicylic Acid—CHUK—PI3K/AKT activation—AKT1—thyroid cancer	0.000132	0.000722	CbGpPWpGaD
Aminosalicylic Acid—CHUK—GAB1 signalosome—AKT1—thyroid cancer	0.000131	0.000716	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Toll-like Receptor Signaling Pathway—AKT1—thyroid cancer	0.000131	0.000716	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—NRAS—thyroid cancer	0.000131	0.000714	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—NRAS—thyroid cancer	0.000131	0.000714	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—NRAS—thyroid cancer	0.000131	0.000714	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—PTEN—thyroid cancer	0.00013	0.000708	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—NRAS—thyroid cancer	0.00013	0.000707	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling of activated FGFR—KRAS—thyroid cancer	0.000129	0.000705	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism—PTGS2—thyroid cancer	0.000129	0.000705	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—NRAS—thyroid cancer	0.000129	0.000701	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Role of LAT2/NTAL/LAB on calcium mobilization—AKT1—thyroid cancer	0.000128	0.0007	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—NDUFA13—thyroid cancer	0.000128	0.000699	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—NRAS—thyroid cancer	0.000128	0.000698	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Breast Cancer Pathway—KRAS—thyroid cancer	0.000128	0.000697	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB4—KRAS—thyroid cancer	0.000127	0.000694	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—CCND1—thyroid cancer	0.000125	0.000679	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—HPGD—thyroid cancer	0.000122	0.000667	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—TPR—thyroid cancer	0.000122	0.000664	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signal transduction—KRAS—thyroid cancer	0.000122	0.000663	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—SLC5A5—thyroid cancer	0.000121	0.000662	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—C-MYB transcription factor network—KRAS—thyroid cancer	0.000121	0.00066	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Activation—NRAS—thyroid cancer	0.000121	0.00066	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR—KRAS—thyroid cancer	0.000121	0.000659	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—LGALS3—thyroid cancer	0.000121	0.000659	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CHST14—thyroid cancer	0.000121	0.000657	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB2—KRAS—thyroid cancer	0.00012	0.000656	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—PRKAR1A—thyroid cancer	0.00012	0.000654	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 signaling—KRAS—thyroid cancer	0.00012	0.000653	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling events of B Cell Receptor (BCR)—KRAS—thyroid cancer	0.000118	0.000643	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—NRAS—thyroid cancer	0.000116	0.000632	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by SCF-KIT—HRAS—thyroid cancer	0.000115	0.000626	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—NRG1—thyroid cancer	0.000114	0.00062	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	0.000114	0.00062	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Breast Cancer Pathway—TP53—thyroid cancer	0.000114	0.00062	CbGpPWpGaD
Aminosalicylic Acid—CHUK—BDNF signaling pathway—HRAS—thyroid cancer	0.000113	0.000616	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism—PTEN—thyroid cancer	0.000113	0.000615	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—KRAS—thyroid cancer	0.000113	0.000614	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—KRAS—thyroid cancer	0.000113	0.000614	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—KRAS—thyroid cancer	0.000113	0.000614	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—TPR—thyroid cancer	0.000113	0.000613	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—KRAS—thyroid cancer	0.000112	0.000609	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—PRKAR1A—thyroid cancer	0.000111	0.000604	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—KRAS—thyroid cancer	0.000111	0.000603	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—KRAS—thyroid cancer	0.00011	0.000601	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling of activated FGFR—HRAS—thyroid cancer	0.00011	0.000599	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—NRG1—thyroid cancer	0.000109	0.000596	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB4—HRAS—thyroid cancer	0.000108	0.00059	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—TCF7L1—thyroid cancer	0.000108	0.000587	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	0.000106	0.000578	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—MEN1—thyroid cancer	0.000106	0.000577	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Activation—KRAS—thyroid cancer	0.000104	0.000568	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signal transduction—HRAS—thyroid cancer	0.000103	0.000563	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—C-MYB transcription factor network—HRAS—thyroid cancer	0.000103	0.000561	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR—HRAS—thyroid cancer	0.000103	0.00056	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Regulation of toll-like receptor signaling pathway—AKT1—thyroid cancer	0.000103	0.000559	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB2—HRAS—thyroid cancer	0.000102	0.000558	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—RXRA—thyroid cancer	0.000102	0.000556	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 signaling—HRAS—thyroid cancer	0.000102	0.000555	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by SCF-KIT—AKT1—thyroid cancer	0.000101	0.000553	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling events of B Cell Receptor (BCR)—HRAS—thyroid cancer	0.0001	0.000547	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—PTEN—thyroid cancer	9.99e-05	0.000545	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—KRAS—thyroid cancer	9.98e-05	0.000544	CbGpPWpGaD
Aminosalicylic Acid—CHUK—BDNF signaling pathway—AKT1—thyroid cancer	9.97e-05	0.000544	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	9.93e-05	0.000541	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	9.92e-05	0.000541	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—HPGD—thyroid cancer	9.72e-05	0.00053	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling of activated FGFR—AKT1—thyroid cancer	9.7e-05	0.000529	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Breast Cancer Pathway—AKT1—thyroid cancer	9.6e-05	0.000523	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—HRAS—thyroid cancer	9.57e-05	0.000522	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—HRAS—thyroid cancer	9.57e-05	0.000522	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—HRAS—thyroid cancer	9.57e-05	0.000522	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB4—AKT1—thyroid cancer	9.55e-05	0.000521	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—HRAS—thyroid cancer	9.49e-05	0.000517	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	9.42e-05	0.000514	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—HRAS—thyroid cancer	9.4e-05	0.000513	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—HRAS—thyroid cancer	9.36e-05	0.000511	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signal transduction—AKT1—thyroid cancer	9.12e-05	0.000497	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—TCF7L1—thyroid cancer	9.1e-05	0.000496	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR—AKT1—thyroid cancer	9.07e-05	0.000495	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—NRAS—thyroid cancer	9.07e-05	0.000494	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB2—AKT1—thyroid cancer	9.03e-05	0.000492	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 signaling—AKT1—thyroid cancer	8.99e-05	0.00049	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—NRAS—thyroid cancer	8.92e-05	0.000486	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Activation—HRAS—thyroid cancer	8.86e-05	0.000483	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling events of B Cell Receptor (BCR)—AKT1—thyroid cancer	8.86e-05	0.000483	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—HRAS—thyroid cancer	8.48e-05	0.000462	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	8.47e-05	0.000462	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—AKT1—thyroid cancer	8.45e-05	0.000461	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—AKT1—thyroid cancer	8.45e-05	0.000461	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—AKT1—thyroid cancer	8.45e-05	0.000461	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CALCA—thyroid cancer	8.42e-05	0.000459	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—AKT1—thyroid cancer	8.38e-05	0.000457	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—AKT1—thyroid cancer	8.3e-05	0.000453	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—AKT1—thyroid cancer	8.27e-05	0.000451	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CDK1—thyroid cancer	8.26e-05	0.00045	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—TP53—thyroid cancer	8.2e-05	0.000447	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	8.18e-05	0.000446	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	7.95e-05	0.000434	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IFNA2—thyroid cancer	7.94e-05	0.000433	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	7.88e-05	0.00043	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—TSHR—thyroid cancer	7.88e-05	0.00043	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Activation—AKT1—thyroid cancer	7.82e-05	0.000427	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—KRAS—thyroid cancer	7.8e-05	0.000426	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PRKAR1A—thyroid cancer	7.75e-05	0.000423	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—KRAS—thyroid cancer	7.67e-05	0.000418	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CDK1—thyroid cancer	7.62e-05	0.000416	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—AKT1—thyroid cancer	7.49e-05	0.000408	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—MEN1—thyroid cancer	7.41e-05	0.000404	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—TPR—thyroid cancer	7.03e-05	0.000383	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PRKAR1A—thyroid cancer	6.92e-05	0.000377	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PTCH1—thyroid cancer	6.7e-05	0.000365	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—TPR—thyroid cancer	6.66e-05	0.000363	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—HRAS—thyroid cancer	6.63e-05	0.000362	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—NRG1—thyroid cancer	6.63e-05	0.000361	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—PRKAR1A—thyroid cancer	6.56e-05	0.000358	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—HRAS—thyroid cancer	6.52e-05	0.000356	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism—AKT1—thyroid cancer	6.5e-05	0.000354	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—PPARG—thyroid cancer	6.44e-05	0.000351	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	6.28e-05	0.000342	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	6.27e-05	0.000342	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—MEN1—thyroid cancer	6.27e-05	0.000342	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—SST—thyroid cancer	6.13e-05	0.000334	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—NRG1—thyroid cancer	6.12e-05	0.000334	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CALCA—thyroid cancer	5.9e-05	0.000322	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—AKT1—thyroid cancer	5.76e-05	0.000314	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—PTEN—thyroid cancer	5.7e-05	0.000311	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—TPR—thyroid cancer	5.58e-05	0.000304	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	5.58e-05	0.000304	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—TERT—thyroid cancer	5.49e-05	0.0003	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PRKAR1A—thyroid cancer	5.49e-05	0.000299	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—PTEN—thyroid cancer	5.47e-05	0.000298	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CDK1—thyroid cancer	5.34e-05	0.000291	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—SLC5A5—thyroid cancer	5.26e-05	0.000287	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—HIF1A—thyroid cancer	5.25e-05	0.000287	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—NRAS—thyroid cancer	5.09e-05	0.000277	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—PTGS2—thyroid cancer	5.06e-05	0.000276	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CALCA—thyroid cancer	4.99e-05	0.000272	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	4.98e-05	0.000271	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	4.93e-05	0.000269	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—NRAS—thyroid cancer	4.88e-05	0.000266	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	4.71e-05	0.000257	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CDK1—thyroid cancer	4.52e-05	0.000246	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—RXRA—thyroid cancer	4.42e-05	0.000241	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—PTEN—thyroid cancer	4.42e-05	0.000241	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—KRAS—thyroid cancer	4.38e-05	0.000239	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—BRAF—thyroid cancer	4.35e-05	0.000237	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	4.3e-05	0.000235	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—NRG1—thyroid cancer	4.29e-05	0.000234	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—KRAS—thyroid cancer	4.2e-05	0.000229	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—SLC5A5—thyroid cancer	4.18e-05	0.000228	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—TERT—thyroid cancer	3.85e-05	0.00021	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—HRAS—thyroid cancer	3.72e-05	0.000203	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—HIF1A—thyroid cancer	3.68e-05	0.000201	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—NRG1—thyroid cancer	3.62e-05	0.000198	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—HRAS—thyroid cancer	3.57e-05	0.000195	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—PTGS2—thyroid cancer	3.51e-05	0.000192	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—RXRA—thyroid cancer	3.51e-05	0.000191	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	3.41e-05	0.000186	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—PTEN—thyroid cancer	3.32e-05	0.000181	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—AKT1—thyroid cancer	3.28e-05	0.000179	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—TERT—thyroid cancer	3.25e-05	0.000177	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—AKT1—thyroid cancer	3.15e-05	0.000172	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—HIF1A—thyroid cancer	3.11e-05	0.00017	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—PTEN—thyroid cancer	3.06e-05	0.000167	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—BRAF—thyroid cancer	3.05e-05	0.000166	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—NRAS—thyroid cancer	2.96e-05	0.000162	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PPARG—thyroid cancer	2.79e-05	0.000152	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—NRAS—thyroid cancer	2.73e-05	0.000149	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—BRAF—thyroid cancer	2.58e-05	0.000141	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—KRAS—thyroid cancer	2.55e-05	0.000139	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—AKT1—thyroid cancer	2.55e-05	0.000139	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—KRAS—thyroid cancer	2.35e-05	0.000128	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CCND1—thyroid cancer	2.22e-05	0.000121	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PPARG—thyroid cancer	2.22e-05	0.000121	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PTGS2—thyroid cancer	2.2e-05	0.00012	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—HRAS—thyroid cancer	2.17e-05	0.000118	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PTEN—thyroid cancer	2.15e-05	0.000117	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—HRAS—thyroid cancer	2e-05	0.000109	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PTEN—thyroid cancer	1.92e-05	0.000104	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—NRAS—thyroid cancer	1.91e-05	0.000104	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—AKT1—thyroid cancer	1.91e-05	0.000104	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—PTEN—thyroid cancer	1.82e-05	9.9e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—AKT1—thyroid cancer	1.77e-05	9.63e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—KRAS—thyroid cancer	1.65e-05	8.99e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—NRAS—thyroid cancer	1.62e-05	8.83e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PTEN—thyroid cancer	1.52e-05	8.29e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—TP53—thyroid cancer	1.46e-05	7.99e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—HRAS—thyroid cancer	1.4e-05	7.64e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—KRAS—thyroid cancer	1.39e-05	7.6e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—AKT1—thyroid cancer	1.24e-05	6.74e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—HRAS—thyroid cancer	1.18e-05	6.46e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—AKT1—thyroid cancer	1.1e-05	6.02e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—AKT1—thyroid cancer	1.05e-05	5.71e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—AKT1—thyroid cancer	8.76e-06	4.78e-05	CbGpPWpGaD
